Calinta Tablet is a commercial drug that is prescribed in the form of Tablet. Calcium Deficiency, Calcium Deficiency, Post Menopausal Osteoporosis are some of its major therapeutic uses. The alternative uses of Calinta Tablet have also been explained below.
The correct dosage of Calinta Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Calinta Tablet include Musculoskeletal Pain (Bone, Muscle or Joint), Diarrhoea, Heartburn. Apart from the aforementioned side effects, Calinta Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Calinta Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Calinta Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Calinta Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Kidney Disease, Heart Disease, Kidney Disease must refrain from the use of Calinta Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Calinta Tablet are listed in the contraindications section below.
Additionally, Calinta Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Calinta Tablet is not safe while driving, and is is not addictive in nature.
Calinta Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Calinta Tablet safe for pregnant women?
Calinta can have harmful effects in pregnant women. If you experience any discomfort after using Calinta, then discontinue the use and take your doctor's advice.
Is the use of Calinta Tablet safe during breastfeeding?
Calinta may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Calinta, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Calinta.
What is the effect of Calinta Tablet on the Kidneys?
Calinta rarely harms the kidneys.
What is the effect of Calinta Tablet on the Liver?
Calinta is rarely harmful for the liver.
What is the effect of Calinta Tablet on the Heart?
Calinta is rarely harmful for the heart.
Calinta Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Calinta Tablet unless your doctor advises you to do so -
Is this Calinta Tablet habit forming or addictive?
Yes, Calinta Tablet cause dependence in some cases. Talk to your doctor before taking it.
Is it safe to drive or operate heavy machinery when consuming?
After taking Calinta Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Calinta Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, Calinta Tablet is useful in treating mental disorders.
Interaction between Food and Calinta Tablet
There isn't any research available on the side effects of taking Calinta Tablet with food.
Interaction between Alcohol and Calinta Tablet
Drinking alcohol while taking Calinta Tablet may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1276-1278
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 340-342
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rocaltrol® (calcitriol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Calcijex® (calcitriol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Boniva® (ibandronate sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Boniva® (ibandronate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pentetate zinc trisodium injection (Zn-DTPA)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 680